CSF2 and cancer: Oftentimes, cancer vaccines include adjuvants, such as granulocyte-macrophage colony-stimulating factor (GM-CSF) or toll-like receptor (TLR) agonists, to specifically increase DC function and antigen presentation efficiency [38].